| For: | Dirjayanto VJ, Audrey J, Simadibrata DM. Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications. World J Gastroenterol 2024; 30(10): 1280-1286 [PMID: 38596495 DOI: 10.3748/wjg.v30.i10.1280] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v30/i10/1280.htm |
| 编号 | Citing Articles |
| 1 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 2 |
Zexuan Ji, Dingni Qu, Yonghao Feng, Xiangrong Qin, Xiaoyong Wang. Effects of supplementing with Saccharomyces boulardii on vonoprazan–amoxicillin dual therapy for naive Helicobacter pylori infection: a randomized controlled trial. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04865-8
|
| 3 |
Zhaoli Ma, Shiling Wang, Furui Wang, Qian Ren.
Research progress of potassium-competitive acid blockers in the treatment of
Helicobacter pylori
. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2544886
|